Maternal Nutrition Market by Type (Multivitamin, Vitamin B, Vitamin D, Calcium, Probiotic, Iron, Others), by Usage (Preconception, Pregnancy, Postpartum), By For (Tablet, Capsule, Powder), by Distribution Channel (Online retailers, Pharmacy stores, Specialty stores, Others) - Global Forecast to 2027
According to MarketsandMarkets, the global maternal nutrition market is estimated to be valued at USD 21.8 billion in 2022. It is projected to reach USD 31.6 billion by 2027, with a CAGR of 7.7%, in terms of value between 2022 and 2027. Maternal nutrition includes products given to women for nutritional growth during pregnancy. These are considered to be a part of nutritional supplements and focus on care of pregnant women in all stages, from the beginning to end of gestation period.
Maternal Nutrition Market Dynamics
Drivers: Rise in awareness regarding nutrition requirements during gestation period
There has been an increase in consumers demanding better nutrition for pregnant women. This is owing to rising awareness regarding nutrition during gestation period and its effect on the child.
Restraints: Price consciousness turns out to be the biggest constraint
The market has been restrained by lower medical expenditure in growing economies, such as those in Asia Pacific region. Owing to lower disposable incomes when compared to other developed economies, such markets pose an entry barrier related to high price of the products.
Opportunities: Rising availability of raw materials and production zones
The price of products has been decreasing and are further set to decrease owing to increased availability of raw materials and increasing prevalence of manufacturing units. This is especially true in emerging economies, such as India where the country has been taking a significant demand share.
Challenges: Unreliable health information on the internet pose a challenge for the market
There has been a rising prevalence for unreliable health information on the internet, which the consumers go through and decide to consume nutritive foods or medication by themselves rather than seeking professional help. This is expected to limit the potential of maternal nutrition market.
By type, multivitamins tend to be the high growth segments in maternal nutrition market.
Multivitamin market has been flourishing in the market due to various channeling strategies by manufacturers. Besides, production zones and availability of raw materials for manufacturing are strengthening the supply of multivitamins in general.
By channel, online retail is expected to showcase the fastest growth
Online retail channels help companies reach consumers with lower investments. This is especially true in emerging markets, where prices influence most of the purchasing decisions, wherein online retail helps reduce cost of products, thereby making it attractive.
Countries which have a developed healthcare system command the majority of maternal nutrition market in the world. Such countries are majorly located in two regions, which are North America and Europe. Owing to higher disposable incomes in general, such regions tend to largely spend on maternal nutrition.
Key Market Players:
Key players in this market include Abbott (US), Koninklijke DSM N.V (Netherlands), GlaxoSmithKline Plc (United Kingdom), Arla Food Ingredients Group (Denmark), Nestle SA (Switzerland), Ausnutria (Hong Kong), Roquette Freres (France), Stepan Company (US), Pharmavite LLC (US), Klaire Labs (US), and others.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.4 REGIONAL SEGMENTATION
1.5 PERIODIZATION CONSIDERED
1.6 CURRENCY CONSIDERED
1.7 VOLUME UNITS CONSIDERED
1.8 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key Data from Secondary Sources
2.1.2 PRIMARY DATA
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 MARKET SIZE ESTIMATION - METHOD 1
2.2.2 MARKET SIZE ESTIMATION - METHOD 2
2.3 DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
2.5 LIMITATIONS OF THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN/SUPPLY CHAIN ANALYSIS
6.3 TECHNOLOGY ANALYSIS
6.4 PRICING ANALYSIS
6.5 ECOSYSTEM/ MARKET MAP
6.6 TRENDS/ DISRUPTION IMPACTING THE CUSTOMER’S BUSINESS
6.7 PATENT ANALYSIS
6.8 TRADE ANALYSIS
6.9 KEY CONFERENCES AND EVENTS IN 2022-2023
6.1 TARIFF AND REGULATORY LANDSCAPE
6.11 PORTER’S FIVE FORCES ANALYSIS
6.12 KEY STAKEHOLDERS & BUYING CRITERIA
6.13 CASE STUDY ANALYSIS
7 MATERNAL NUTRITION MARKET, BY TYPE
7.1 INTRODUCTION
7.2 MULTIVITAMIN
7.3 VITAMIN B
7.4 VITAMIN D
7.5 CALCIUM
7.6 PROBIOTIC
7.7 IRON
7.8 CALCIUM
7.9 OTHER TYPES
8 MATERNAL NUTRITION MARKET, BY USAGE
8.1 INTRODUCTION
8.2 PRECONCEPTION
8.3 PREGNANCY
8.4 POSTPARTUM
9 MATERNAL NUTRITION MARKET, BY FORM
9.1 INTRODUCTION
9.2 TABLET
9.3 CAPSULE
9.4 POWDER
10 MATERNAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL
10.1 INTRODUCTION
10.2 ONLINE RETAILERS
10.3 PHARMACY STORES
10.4 SPECIALTY STORES
10.5 OTHER DISTRIBUTION CHANNEL
11 MATERNAL NUTRITION MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 AUSTRALIA & NEW ZEALAND
11.4.5 REST OF ASIA PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 REST OF THE WORLD
11.6.1 AFRICA
11.6.2 MIDDLE EAST
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS*
12.3 KEY PLAYERS STRATEGIES
12.4 COMPANY REVENUE ANALYSIS OF TOP 5 MARKET PLAYERS
12.5 COMPANY EVALUATION QUADRANT
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPETITIVE BENCHMARKING
12.6 PRODUCT FOOTPRINTS
12.7 STARTUP/SME EVALUATION QUADRANT
12.7.1 PROGRESSIVE COMPANIES
12.7.2 STARTING BLOCKS
12.7.3 RESPONSIVE COMPANIES
12.7.4 DYNAMIC COMPANIES
12.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
12.8.1 NEW PRODUCT LAUNCHES
12.8.2 DEALS
12.8.3 OTHER DEVELOPMENTS
12.8.4 PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES
13 COMPANY PROFILES
13.1 ABBOTT
13.2 KONINKLIJKE DSM N.V.
13.3 GLAXOSMITHKLINE PLC
13.4 ARLA FOOD INGREDIENTS GROUP
13.5 NESTLE SA
13.6 AUSNUTRIA
13.7 ROQUETTE FRERES
13.8 STEPAN COMPANY
13.9 PHARMAVITE LLC
13.10 KLAIRE LABS
Note: Currently, list of only 10 companies have been provided. However, this section covers 12-15 key company profiles which include business overview, recent financials, product offerings, key strategies, and swot analysis. recent financials can be provided based on data/information availability in public domain. The list of companies mentioned above can be altered depending upon client’s interest
14 APPENDIX
Note: The TOC prepared above is tentative and may subject to change, based on the research progress
Growth opportunities and latent adjacency in Maternal Nutrition Market